Rami Homsi1, Alois Martin Sprinkart1, Jürgen Gieseke1,2, Julian Luetkens1, Michael Meier-Schroers1, Darius Dabir1, Daniel Kuetting1, Christian Marx1, Hans Schild1, and Daniel Thomas1
1Radiology, University Hospital Bonn, Bonn, Germany, 2Philips Healthcare, Hamburg, Germany
Synopsis
In a Cardiac Magnetic Resonance based approach the study reveals a relationship between epicardial fat and aortic stiffness which are both associated with cardiovascular risk and disease.PURPOSE
Aortic stiffness and the amount of epicardial fat are both associated with cardiovascular risk. Cardiac Magnetic
Resonance (CMR) can accurately determine epi- and paracardial fat volumes (EFV, ParaFV) and it can also assess aortic stiffness by measuring the aortic
pulse wave velocity (PWV)
1-3. We investigated PWV, EFV and ParaFV in hypertensive
patients and healthy controls to evaluate if and resp. how they are correlated and
how they correlate with the presence of diabetes mellitus (DM) and myocardial
infarction (MI).
Methods
215 subjects (134 men; mean age
57.3±41.4year, mean BMI 27.9±5.3kg/m²) that consisted of 59 healthy controls
and 156 hypertensive patients underwent comprehensive CMR exam (1.5 Tesla,
Philips Healthcare).
Aortic PWV was assessed by a 2-dimensional (2D) velocity-encoded
sequence perpendicular through the aorta ascendens (AA ) and descendens (AD)
with retrospective ECG-gating during
free breathing (number of heart phases = 130, maximum VE = 150cm/sec). PWV was
calculated by dividing the distance between the section through the AA and
through the proximal AD by the time between the arrival of the tangents of the velocity
waveform at the section through AA and AD, respectively (figure 1) (Segment, version 1.9,
R3918; http://segment.heiberg.se) 1.
EFV & ParaFV were determined
using a 3D transversal ECG-triggered and respiratory navigator gated
mDixon-sequence 2,4 (scan time: 7.5min; voxel size
1.5 x 1.5 x 3.0mm³; TR / TE1 / TE2 / α : 5.4ms / 1.8ms / 4.0ms / 20°; PI SENSE, acceleration factor
1.5 in both phase encoding directions; T2 prepulse 50ms; trigger delay: end-diastole;
acquisition window: 100-156ms). In-phase, Opposed-phase, Water only (W), and
Fat only (F) images were reconstructed online at the scanner 5. Fat-fraction maps were
computed based on F- and W-images with an appropriate noise threshold and correction
for relaxation effects to identify voxels containing ≥50% fat (figure 2).
Results
Mean PWV was
8.8±2.8, mean EFV was 66.3±29.9ml/m² and mean ParaFV was 81.1±48.6ml/m².
PWV correlated
with EFV (R= 0.436, P=<0.001 [Spearman-rho]).
After
adjustment for age, BMI and gender, epicardial fat volume was statistically
significant associated with PWV (slope coefficient
1.737; P=0.017 with a confidence interval [CI] of 0.309-3.166).
(figure 2). No association was found with ParaFV (P=0.091).
Healthy controls had lower PWV values
and EFV&ParaFV than hypertensive patients. Hypertensive patients were divided
into
(a) “group HTN” (N=156; patients without DM or MI),
(b) “group HTN+DM” (N=19; patients with DM but without MI), and
(c) “group MI” (N=53; patients with MI).
After adjustment for age,
BMI and gender, “group HTN+DM” revealed higher values of PWV and EFV&ParaFV than “group HTN” (EFV P=0.012; ParaFV P=0.028; PWV P=0.028).
“Group MI” revealed
higher values of PWV and EFV than “group HTN” (EFV P<0.004; PWV P<0.034;
ParaFV P=0.249). No differences were observed between “group MI” and “group
DM”.
Discussion
A CMR-based quantification of cardiovascular risk parameters
revealed a relationship of aortic stiffness and epicardial fat volumes with each other
and with cardiovascular risk.
This may be explained by similar (pro-)inflammatory mechanisms, which act in epicardial
fat and which also promote aortic atherosclerosis 3,6.
Future studies should
concentrate on the investigation of the relationships with regard to the
prediction of cardiovascular events.
Conclusion
Aortic
stiffness and epicardial fat volumes are related with each other and with CV risk,
possibly influenced by similar (pro-)inflammatory mechanisms.
Acknowledgements
No acknowledgement found.References
[1] Grotenhuis, H.B.,
et al. J Magn Reson Imaging, 2009. 30(3): p. 521-6. [2] Homsi, R., et al. Int J
Cardiovasc Imaging, 2015. [3] Dey,
D., et al. Cardiovasc Diagn Ther, 2012. 2(2): p. 85-93. [4] Bornert, P., et al.
Magn Reson Med, 2014. 71(1): p. 156-63. [5] Eggers, H., et al. Magn Reson Med,
2011. 65(1): p. 96-107.
[6] Ito, T., et al.
Eur Heart J Cardiovasc Imaging, 2012. 13(5): p. 408-15.